Michael Conley
Family · Ontario, CANPI 1952647638
Payments from drug & device makers
Across 214 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$549
- Otsuka America Pharmaceutical, Inc.$526
- Johnson & Johnson$358
- Alkermes, Inc.$235
- Lundbeck LLC$195
- plus $900 from 10 others
What the payments were for
- Food & beverage$4,152100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 60 | $1,390 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 37 | $549 |
| Otsuka America Pharmaceutical, Inc. | 30 | $526 |
| Johnson & Johnson(2 entities) | 15 | $358 |
| Alkermes, Inc. | 9 | $235 |
| Lundbeck LLC | 11 | $195 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $181 |
| Neurocrine Biosciences, Inc. | 10 | $181 |
| Axsome Therapeutics, Inc. | 6 | $115 |
| Corium, LLC | 8 | $110 |
| Vanda Pharmaceuticals Inc. | 6 | $92 |
| Teva Pharmaceuticals USA, Inc. | 4 | $82 |
| Collegium Pharmaceutical, Inc. | 4 | $80 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Olympus America Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$118
How this compares
$4,152 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 27 | $1,155 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 42 | $815 |
| Alprazolam | 40 | $338 |
| Bupropion XlBupropion Hcl | 18 | $266 |
| Lithium Carbonate ErLithium Carbonate | 13 | $240 |
| Clonazepam | 24 | $236 |
| Lorazepam | 18 | $215 |
| Gabapentin | 22 | $197 |
| Diazepam | 14 | $153 |
| Hydroxyzine Hcl | 12 | $129 |
| Baclofen | 11 | $129 |
| Aripiprazole | 11 | $128 |
| Quetiapine Fumarate | 15 | $81 |
Paid to pharmacies, not to this prescriber.
Other family in Ontario
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.